Search Results 521-530 of 16691 for Trazodone

  1. A Study To Evaluate The Safety, Tolerability, And Effects On Blood And Urine Markers Of Single Ascending Dose Of GSK4771261 In Healthy Participants And Participants With Autosomal Dominant Polycystic Kidney Disease - Mayo Clinic

    This is a study where a new drug, called GSK4771261 is being tested. Neither the study doctors, study staff or participants will be aware of what treatment is ...

  2. Etodolac (oral route) - Side effects & dosage - Mayo Clinic

    Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used to treat mild to moderate pain, and helps to relieve symptoms of arthritis (eg, osteoarthritis ...

  3. A Study to Evaluate Rozanolixizumab to Treat Patients with Generalized Myasthenia Gravis - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...

  4. Clonidine hydrochloride (oral route) - Mayo Clinic

    Clonidine extended-release suspension is used to treat attention deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central ...

  5. Eletriptan (oral route) - Mayo Clinic

    Eletriptan is not an ordinary pain reliever. It will not relieve any kind of pain other than migraine headaches. This medicine is usually used for people whose ...

  6. A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical Treatment CTEPH - Mayo Clinic

    A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical ...

  7. AMZ002 Compared to Vigabatrin - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of AMZ002, compared to vigabatrin, in the treatment of infantle spasms (IS). Participation ...

  8. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor- ...

  9. Neurosurgery - Clinical trials

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

  10. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Bevacizumab blocks the ability of tumors to grow new blood vessels and ...